NIH-funded research P30 center grant

Down syndrome Alzheimer's research program

Official title: Core H: Down Syndrome Core

Funded at University of California-Irvine · NIH-11368558 · Data updated 2026-05-14

This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check NIH RePORTER for its current status.

This program follows adults with Down syndrome to track yearly brain and fluid markers tied to Alzheimer's disease so we can learn when and how dementia starts.

Quick facts

Grant typeP30 center grant
Study typeNIH-funded research
Funding institutionUniversity of California-Irvine
NIH-funded
Lab location1 site (Irvine, United States)
Project IDNIH-11368558 on NIH RePORTER

Who could benefit from this research

Could help

Adults with a clinical diagnosis of Down syndrome aged 18 to 70 who can travel to UC Irvine for annual visits and are willing to undergo imaging and provide fluid samples are ideal candidates.

Less likely to help

People without Down syndrome, those under 18 or over 70, or anyone unable or unwilling to attend visits or provide samples are unlikely to benefit directly from participating.

What this research studies

You would join a group of about 50 adults with Down syndrome, ages 18 to 70, who are seen once a year at UC Irvine. Each visit includes clinical and thinking tests, brain scans, and fluid (blood/spinal fluid) collection, and participants are invited to consider brain donation. The program focuses on including people from diverse racial and ethnic backgrounds and studies social factors that might affect when dementia begins. It also pilots new outcome measures and works with other research teams to share findings and ideas.

Why it matters

Potential benefit: If successful, this work could help detect Alzheimer-related changes earlier in people with Down syndrome and guide better care and future treatments for this group.

How similar studies have gone: Previous longitudinal studies in Down syndrome have successfully mapped amyloid and other biomarker changes over time, but many lacked diverse participants and novel outcome measures.

Where this research is happening

  • University of California-Irvine
    Irvine, United States
    Active

Researchers

  • Principal investigator: Head, Elizabeth — University of California-Irvine
  • Study coordinator: Head, Elizabeth

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.